. 2022 Jan 10;70(2):577–583. doi: 10.1021/acs.jafc.1c07520

Table 1. Anti-/Pro-inflammatory Cytokines’ Ratio^a.

	C	LPS	H2 [100μM]
IL10/IFN-γ	1.05 ± 0.14^a	0.75 ± 0.15^b	1.10 ± 0.19^a
IL10/TNF	0.99 ± 0.07^a	0.88 ± 0.05^a	1.14 ± 0.11^b
IL10/IL-6	1.01 ± 0.10^a	0.90 ± 0.03^a	0.96 ± 0.07^a

	C	LPS	H3 [25μM]
IL10/IFN-γ	1.00 ± 0.03^a	0.93 ± 0.05^a	1.34 ± 0.06^b
IL10/TNF	1.00 ± 0.02^a	0.92 ± 0.02^a	1.44 ± 0.12^b
IL10/IL-6	1.00 ± 0.02^a	0.90 ± 0.01^a	1.32 ± 0.13^b

Ratios between anti-inflammatory (IL-10) and pro-inflammatory (IFN-γ, TNF, and IL-6) cytokines quantified in HepG2 cells stimulated or not with LPS and treated with H2 (100 μM) or H3 (25 μM). Data are presented as mean ± SD and were analyzed by one-way ANOVA, followed by Tukey’s post-hoc test. Different letters indicate statistically significant differences (p ≤ 0.05). C, unstimulated control group; IFN-γ, interferon-γ; IL, interleukin; LPS, lipopolysaccharide-stimulated cells; TNF, tumor necrosis factor.

Table 1. Anti-/Pro-inflammatory Cytokines’ Ratioa.

Table 1. Anti-/Pro-inflammatory Cytokines’ Ratio^a.